GENE ONLINE|News &
Opinion
Blog

Gene Editing
A New Multiplex CRISPR Method in Plants Can Generate High-Order Mutants in One Shot
2021-04-04
A Brief Sketch of Gene Therapy Vectors and Delivery Methods
2021-04-03
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
10 Top Gene Therapy Companies in 2021
2021-03-26
Singapore Researchers Design New C to G Base Editor to Correct Disease-Associated Mutations
2021-03-18
CRISPR-Based Analgesics Aspire to Mitigate Opioid Crisis
2021-03-16
Beam Therapeutics Acquires Georgia Tech Spin Out, Seeks Non-Viral Gene Therapy Delivery Vehicles
2021-02-25
BIOCEO21 Highlights: Novel CRISPR Delivery Method Puts the Spotlight on this Early Stage Biotech
2021-02-18
TALEN Proves to be a Better Gene Editor than CRISPR in Densely Packed DNA
2021-02-01
Using Electricity and CRISPR, Scientists Enable Inheritable Data Storage on Bacterial DNA
2021-01-24
JPM Healthcare Conference Highlights: Editas Upbeat about EDIT-101 Success, Verve Continues to Tackle Cholesterol
2021-01-15
GeneOnline’s Top 10 Headlines of the Year
2020-12-30
Japan’s AnGes Acquires EmendoBio, Eying High Precision Gene-Editing Technology
2020-12-17
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
1 2 3 4 5 6
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top